OR WAIT null SECS
Major expansions in Argentina and Singapore point to heightened biopharma focus on emerging markets
Following its planned acquisition by AmerisourceBergen, World Courier (Stamford, CT) is getting more public about its recent internal investments. The company is currently undergoing audits of a new Buenos Aires, Argentina depot that quadruples the size of existing facilities there, to 37,000 sq. ft. The facility is expected to be fully operational next month. “Customer demand for clinical trial storage in Argentina and throughout Latin America continues to remain very strong,” said Carlos Jankowski, global executive director for the company’s Clinical Trial Supply Chain Services Division.
In recent months, World Courier has also expanded its Singapore facility to 135,000 sq.ft., making it the largest of the company’s 13 facilities around the world. Other facilities have expanded, or are in the process of being upgraded, in Sao Paulo, Santiago, Beijing, Bogota, Bengaluru (India), Mexico City, Lima, Moscow and Johannesburg. All these facilities are said to incorporate GMP-compliant processes, have validated storage for controlled ambient, refrigerated, frozen and deep-frozen storage, and are staffed with licensed pharmacists. Around this infrastructure, the company wraps an additional 137 ISO 9001-certified offices in 52 countries, and says that it is currently handling projects for 500 biopharma companies worldwide.